update 2017
play

Update 2017 What we can do to prevent & treat Richard - PowerPoint PPT Presentation

Asthma Exacerbations Update 2017 What we can do to prevent & treat Richard Hendershot, M.D., FAAAAI Asthma & Allergy Salt Lake Clinic Asthma Exacerbations Update 2017 What we can do to prevent and treat Richard Hendershot, M.D.,


  1. Asthma Exacerbations Update 2017 What we can do to prevent & treat Richard Hendershot, M.D., FAAAAI Asthma & Allergy – Salt Lake Clinic

  2. Asthma Exacerbations Update 2017 What we can do to prevent and treat Richard Hendershot, M.D., FAAAAI Asthma & Allergy – Salt Lake Clinic

  3. Asthma Exacerbations Update 2017 Etiology – increase in disease activity

  4. Asthma exacerbations - explode A pressure phenomenon +/- • How much underlying disease/ inflammation: o Physiologic severity, allergy, last exacerbation, SABA use, functional capacity (exercise), ICS use. • Severity of trigger (s) o Rhinovirus vs RSV vs influenza, SMOG, allergy J Allergy Clin Immunol 2008;122:697-9.

  5. Virus is the major trigger of asthma exacerbations (70- 85% of the time based on age and risk). Note: allergy, atypical bacteria and SMOG frequently make this worse. OR 2.3 (virus only) OR 8.4 (virus + allergy)

  6. 278 pts w/ moderate to severe asthma exacerbations tx’d w/ telithromycin + prednisone vs placebo vs prednisone. Note increased time to improvement in symptoms and decreased symptoms with addition of telithromycin. Is there a role for macrolides in treating exacerbations? I routinely do not b/c data is not impressive, unless already failed OCS or very JACI 2006;117:1233-6 severe exacerbation.

  7. Asthma Exacerbations - etiology URIs (virus) are the primary cause of an asthma exacerbation • Rhinovirus is the leading cause in adults & children • Huge seasonal peak – Fall/ September is the highest, lowest summer • Allergy, pollution, non-adherence amplify this. o Virus alone (OR 2.3) vs allergen (cat in home) exposure + virus (OR 8.4) o Adherence to ICS is the most effective way to decrease this risk. o OCS in the last 12 months highest predictor of repeat exacerbation o High SABA use strong predictor of exacerbations

  8. Asthma exacerbations – viral increase to inflammation & bronchial reactivity URIs/ viral infections cause 85% of asthma exacerbations in peds (75% adults). • Rhinovirus causes 2/3 of viral triggered exacerbations o Rhinovirus and/ or RSV and/or influenza all trigger reactions but c/b SMOG, allergen, cold air, exercise, etc. BMJ 1995;310:1225-8

  9. Asthma exacerbations – viral increase to inflammation & bronchial reactivity URIs/ viral infections cause 85% in peds (75% adults) of asthma exacerbations – responsible for seasonal variation. • Rhinovirus causes 2/3 of viral triggered infections • Why September – kids & school o Note: most studies indicate virus attenuates an additional trigger. BMJ 1995;310:1225-8

  10. Asthma exacerbation seasonal Sept. peak is broken out by age • Peds 2-15 show greatest variabilty • Pts 16-49 yo still show a small Sept peak • Adults >50 is this flu season or delay in rhinovirus getting to the elderly (no data on adults over 50 for viral PCR) Proc Am Thorac Soc 2007;4:591-6

  11. Ideally – measure viral infection, Goal – reduce exacerbations & inflammation & reactivity at morbidity, use markers of home. significance to accomplish that. • PCR to nasal lavage is currently • Controller:Reliever ratio >0.50, impractical. patients use 2x as many controllers as relievers. • eNO did not work well and too • High SABA use correlates w/ expensive for home use. increased morbidity. • Home PEF failed to help as well. • Controller Rx (s) do not correlate o So we use surrogate markers & we need to be able to measure it on a with exacerbations population basis. Am J Manag Care. 2010;16(5):327-333

  12. Asthma exacerbations – Update 2017 What we can do to prevent & treat. • High use of ICS helps. • High need/ use of SABA is a surrogate marker for bronchial reactivity & inflammation. • This is complex because it depends on the patient/ parent’s priorities and beliefs. o This is a system problem & challenge. o There are tools available to help.

  13. ICS is more effective than LTRA or lower dose ICS/ LABA Note BADGER study See table JACI 2008;122:741-7

  14. JACI 2008;122:741-7 NEJM 2010;362:975-85

  15. Place slide text here. Resize shape behind text to properly fit content. Overall we are doing pretty good, but for some patients can we do better?

  16. 3 pts hospitalized, 13 pts in ER – 12 total not meeting HEDIS, 8 ended up in ER, some hospitalized

  17. What do we do ? Utah stats per year: • 40 deaths • >1500 hospitalizations • >7000 ED visits

  18. Asthma exacerbations – key messages Factors we CAN change Factors we CANNOT change. • Synergistic relationship between viral • Before puberty boys exacerbate > infection/ allergy sensitization & girls. exposure & exacerbations. • After puberty, females exacerbate • Frequent exacerbations indicate more, get sicker, hospitalized comorbidity especially psychosocial factors. longer • ICS + LABA helps, LABA without ICS is • Predictable seasonal epidemics inappropriate. Off-label of PRN ICS/ • Most exacerbations virally formoteral has proven efficacy. triggered. • +LTRA in peds helps reduce fall exacerbations. JACI 2008;122:662-8

  19. Big Picture, the more controller med used regularly (ICS, ICS/LABA or LTRA taken) and less SABA required regularly to treat asthma the lower the risk of an exacerbation. Distribution of a controller does not help. Am J Manag Care. 2010;16(5):327-333

  20. Asthma exacerbations – what can we do about them? 2 addressable problems: 1. Address comorbidities including psycho-social . 2. Align goals & expectations between docs & pts. **Key relationships

  21. Asthma exacerbations – what can we do about them? Comorbidities : 1. Psychosocial – cost, divorce, child in charge, poor technique, etc. 2. Allergy – cat/dog/ guinea pig/ bird 3. Sinusitis 4. Tobacco/ SMOG 5. AERD 6. GERD 7. Hyper-eosinophilia, etc.

  22. Asthma exacerbations – what can we do about them? Psychosocial: Relationships, relationships, relationships (care manager to track), doctor to educate and create a plan Discussion on approaches • Divorce? • Cost? • Child in charge of therapy? • Poor technique? • Other problems with discussion . . .

  23. Asthma exacerbations – what can we do about them? Other comorbidities : 1. Allergy – cat/dog/ guinea pig/ bird, only about 5% get rid of their pets so modify environment and trial AIT 2. Sinusitis – consider above too 3. Tobacco/ SMOG – quit, avoid, stay indoors on bad days. 4. AERD – ASA desensitization, LTRA 5. GERD – rare, worth a trial 6. Hyper-eosinophilia, etc, new med, etc

  24. Asthma exacerbations – what can we do about them? Goals & Expectations/ pt perceptions: 1. Not allergic to my dog or cat 2. OCS 2-5 times a year OK. 3. ED/ hospitalization twice a year OK. 4. Fear of steroids – ICS vs OCS 5. SABA use 2-4 times a day OK. 6. Preference for naturopathic therapy, standard medical care is harmful. 7. Coughing after exertion – normal. **Relationships key to this

  25. Another great idea: My brother in law worked with a farmer in upstate New York who did this with his tractor. It was terrifying and awesome at the same time.

  26. Asthma exacerbations – what can we do about them? Goals & Expectations/ pt perceptions: ---OCS 2-5 times a year OK/ ED hospitalizations OK. Peds OCS use: • short term crazy & hyperactive (hangry) • Long term – loss of height, see adult long term Adult OCS use: • Short term – cranky/ hungry (extra hangry) • long term - DM-II, osteoporosis, compression fractures, loss of FEV1

  27. Asthma exacerbations – what can we do about them? Goals & Expectations/ pt perceptions Fear of all steroids • Yes, corticosteroids are bad – but dose matters. • Pred 60mg QD x 5 days = 300mg • Fluticase ICS 200mcg QD x 365 days x 10% efficiency = 7300 mcg = 7.3mg • 300mg/7.3mg = 41 fold higher dose per year with 1 exacerbation per year for OCS

  28. Asthma exacerbations – what can we do about them? Goals & Expectations/ pt perceptions High SABA use OK • Asthma is 3 things: bronchial reactivity, inflammation, mucus • SABA only treats bronchial reactivity and leaves other alone • Sole SABA use (no ICS) correlates with increased risk of death, hospitalizations, ED, decreased exercise capacity

  29. Asthma exacerbations – what can we do about them? Goals & Expectations/ pt perceptions: 1. Preference for naturopathic therapy, standard medical care is harmful – ideas? My experience supports patience and a good relationship is key here. 2. Coughing after exertion, I avoid or have my child avoid exercise – education, all asthmatics should be so well treated they can exercise as much as they prefer.

  30. Asthma Exacerbations Update 2017 Big picture: Intermountain Healthcare as a whole is doing well w/ HEDIS. However, pts are still severely exacerbating & those are the pts failing. • Success = High ICS/ LTRA or ICS+LABA use with low regular SABA use. Cute picture, but if this occurs • Physician & care manager relationships it largely means we failed as a & communication are key to making this system. WE CAN DO BETTER. happen.

  31. Asthma Exacerbations Update 2017 • Discussion & questions & ideas. • I want your ideas and your experience with how this can be done better as individuals and as a system.

Download Presentation
Download Policy: The content available on the website is offered to you 'AS IS' for your personal information and use only. It cannot be commercialized, licensed, or distributed on other websites without prior consent from the author. To download a presentation, simply click this link. If you encounter any difficulties during the download process, it's possible that the publisher has removed the file from their server.

Recommend


More recommend